Form D · Other Health Care
Calibrate Health NewCo, LLC
New York, NY · CIK 0001997883
Offering snapshot reported Nov 1, 2023 · SEC filing
- Reported sold
- $29.1M Offering amount: $29.1M
- Investors reported
- 145 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 30, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 1, 2023 | Initial | $29,050,000 | No comparison | 145 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496232
Source: Form D, filed Nov 1, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Avinash Amin | Director |
| Alex Marcantonio | Director |
| Emily Melton | Director |
| Kira Wampler | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
228 Park Ave South, #76071
New York, NY, 10003
New York, NY, 10003